Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
07/2003
07/17/2003WO2002099124A3 Characterising polypeptides
07/17/2003US20030135063 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor
07/17/2003US20030135057 5-amino- and 5-thio- substituted; prepared from a methylenedithietane intermediate
07/17/2003US20030135053 For use in human or veterinary conditions, that may be dermatological, rheumatic, respiratory, or cardiovascular and may be used in cosmetics
07/17/2003US20030135046 Synthesis of heteroarylamine intermediate compounds
07/17/2003US20030135045 Glycoprotein IIb/IIIa antagonists
07/17/2003US20030134880 Novel cd23 inhibitors
07/17/2003US20030134878 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
07/17/2003US20030134874 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
07/17/2003US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus
07/17/2003US20030134857 Synergistic insecticide mixtures
07/17/2003US20030134848 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholin receptors activators
07/17/2003US20030134836 Substituted arylamine derivatives and methods of use
07/17/2003US20030133992 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
07/17/2003US20030131422 Primary intermediates for oxidative coloration of hair
07/17/2003CA2471752A1 Carboxamidine derivatives and their use in the treatment of vascular diseases
07/16/2003EP1327630A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
07/16/2003EP1327628A2 Lipidization of hydrophilic molecules
07/16/2003EP1326993A2 PRODUCTION OF g(a)-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM
07/16/2003EP1326858A2 Piperidine compounds as anti-allergic
07/16/2003EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
07/16/2003EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance
07/16/2003EP1326838A1 Novel crystalline forms of a factor xa inhibitor
07/16/2003EP1326837A1 Crystal forms of 1- 6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride
07/16/2003EP1326836A1 Process for making 3-amino-2-chloro-4-methylpyridine
07/16/2003EP1326835A1 Benzamide compounds as apo b secretion inhibitors
07/16/2003EP1326834A2 2-substituted heterocyclic compounds
07/16/2003EP1326833A2 Substituted heterocyclic compounds for treating multidrug resistance
07/16/2003EP1326827A2 Insecticidal 1,8-naphthalenedicarboxamides
07/16/2003EP1284733A4 Novel processes for preparing torsemide intermediate
07/16/2003EP1175416B1 Heteroaryl diazacycloalkanes, their preparation and use
07/16/2003EP1155000B1 2-aminopyridines containing fused ring substituents
07/16/2003CN1430608A Substituted iminoazines
07/16/2003CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha
07/16/2003CN1430606A New process
07/16/2003CN1430602A Ary-and heteroaryl sulfonates compounds
07/16/2003CN1430596A New gamma selective retinoids
07/16/2003CN1114608C Novel camptothecine analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same
07/16/2003CN1114598C Aromatic compounds and pharmaceutical compositions containing them
07/16/2003CN1114596C Biphenyl derivatives
07/16/2003CN1114595C Process for preparing pyridyl methyl ester isothiocy anide
07/16/2003CN1114594C D4 receptor selectivity piperazine derivatives
07/16/2003CN1114593C Preparation of 2-substituted pyridines
07/16/2003CN1114591C Cyclic amide compounds
07/15/2003US6593493 2-(Carboxy(unsaturated)alkyl)-1-(haloalkoxy)benzene derivatives; retinoid X receptors; cardiovascular, skin, eating and vision disorders; anticarcinogenic agents; non-insulin-dependent diabetes
07/15/2003US6593486 Reacting halobenzoic acid with 2,2,2-trifluoroethanol; thenhaloacetonitrile
07/15/2003US6593475 Preparation of derivative of 3-sulfonamido-4-phenylaminopyridine
07/15/2003US6593472 NK-1 receptor active amine oxide prodrugs
07/15/2003US6593471 Synthesis of heteroarylamine intermediate compounds
07/15/2003US6593438 Catalyst composition and method of polymerization
07/15/2003US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery
07/15/2003US6593330 Compounds and their use
07/15/2003US6593327 Compounds and compositions as protease inhibitors
07/15/2003US6592633 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected
07/15/2003CA2238465C Triaromatic compounds, compositions containing them and uses
07/15/2003CA2218766C Bicyclic-aromatic compounds
07/15/2003CA2056191C Herbicidal carboxamide derivatives
07/10/2003WO2003055874A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
07/10/2003WO2003055861A1 Benzocyclodecane derivatives with antitumor activity
07/10/2003WO2003055851A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
07/10/2003WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
07/10/2003WO2003055848A2 Urea derivatives as vr1- antagonists
07/10/2003WO2003055843A1 Agaricoglycerides and analogs
07/10/2003WO2003055482A1 Amide derivatives as gk activators
07/10/2003WO2001098248A3 Hiv integrase inhibitors
07/10/2003US20030130521 Enantioselective reduction to produce an optically active hydroxyethylpyridine derivative; further derivatized to an intermediate such as a dihydroxyethylpyridine derivative; use of microorganism derived carbonyl-reducing enzymes
07/10/2003US20030130520 Producing substituted 2-nitro-guanidine derivatives.
07/10/2003US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
07/10/2003US20030130511 Replacing a halogen atom with an electrophilic group (e.g., a formyl group) using either a mixture of an organomagnesium halide and an alkyllithium or a reaction product of the two, such as trialkylmagnesium lithium
07/10/2003US20030130508 3,5-bis(trifluoromethyl)phenylmethylene-substituted derivatives of nicotamide or pyridinylaminocarbonyl compounds; used to treat disorders of the central nervous system such as anxiety, depression and psychosis.
07/10/2003US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion
07/10/2003US20030130345 C2-substituted idan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
07/10/2003US20030130342 Such as anticoagulant 3-(6-(4-(aminoiminomethyl)phenyl methoxy)-2-methyl-2H-1-benzopyran-2-yl)propanoic acid hydrochloride
07/10/2003US20030130339 Such as (E)-2-pyridineethenyl-4-fluorobenzyl sulfone; antitumor/anticancer agents
07/10/2003US20030130296 FXR NR1H4 nuclear receptor binding compounds
07/10/2003US20030130295 Substituted 2-aminoacetamides and the use thereof
07/10/2003US20030130289 Inhibitors of glycogen synthase kinase 3
07/10/2003US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders
07/10/2003US20030130232 Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect
07/10/2003US20030129670 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential
07/10/2003US20030129552 Color photothermography
07/10/2003US20030127129 Charge transfer material, and photoelectric conversion device and photoelectric cell using same, and pyridine compound
07/10/2003CA2471910A1 Benzocyclodecane derivatives with antitumor activity
07/10/2003CA2471049A1 Amide derivatives as gk activators
07/10/2003CA2469967A1 Urea derivatives as vr1- antagonists
07/09/2003EP1325925A1 Chromium catalysts active in olefin polymerization
07/09/2003EP1325912A1 2,2-diphenylbutanamide derivatives and medicines containing the same
07/09/2003EP1325908A1 Process for the preparation of an enantiomerically enriched thio compound
07/09/2003EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage
07/09/2003EP1325671A1 Organometallic compounds and emission-shifting organic electrophosphorescence
07/09/2003EP1324996A2 Substituted aryl ketones
07/09/2003EP1324986A1 Nitrogen-containing compounds and their use as glycine transport inhibitors
07/09/2003EP1324981A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors
07/09/2003EP1165496B1 Substituted aniline compounds
07/09/2003EP1066251B1 Method for the production of 1,3-disubstituted 2-nitroguanidines
07/09/2003CN1429225A C10 carbonate substituted taxanes as antitumor agents
07/09/2003CN1429210A Substituted thioacetamides
07/09/2003CN1429200A Anthranyl amides and their use as medicaments
07/09/2003CN1429199A Insecticidal 1,8-naphthalenedicarboxamides
07/09/2003CN1429198A Novel phenyl-proparylether derivatives